Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,967.38
(
1.18%
)
US TECH 100
25,130.00
(
1.76%
)
Dow Jones
48,535.99
(
0.66%
)
Brent Oil
92.69
(
-2.91%
)
Bitcoin
74,267.18
(
-0.31%
)
News Focus
News Focus
Post# of 22621
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rstar

Send PM Follow Ignore
Followers 414
Posts 43540
Boards Moderated 0
Alias Born 08/24/2005

rstar

Re: N.C.LUCKY(7) post# 22541

Sunday, 03/29/2026 11:12:36 AM

Sunday, March 29, 2026 11:12:36 AM

Post# of 22621
also note that the same doc who ran the epidiolex trial to fda approval
is also running DeFloria's AJA001 trial!
expecting they announce the start of ph 2 trials very soon.
when ph 2 results start rolling in, if they are positive, that will give strong indications of fda approval
and when they might start considering offers for defloria from big pharm imo and also suggested in defloria presentation.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CWBHF News
More CWBHF News